重要内容提示： ? 每股分配比例：每股派发现金红利人民币 0.19 元（含税）。 为落实《新华文轩出版传媒股份有限公司"提质增效重回报"专项行 动方案》，增强投资者回报、提升投资者获得感，新华文轩出版传媒股份 有限公司（以下简称"公司"或"本公司"）拟进行 2025 年半年度利润分 配。 公司 2025 年半年度（未经审计）实现归属于上市公司股东净利润人民 币 8.57 亿元，截至 2025 年 6 月 30 日，母公司报表中未分配利润为人民币 年度拟以实施权益分派股权登记日登记的总股本为基数分配利润。本次利 润分配建议方案如下： 公司拟向全体股东每股派发现金红利人民币 0.19 元（含税）。截至 2025 年 6 月 30 日，公司总股本 123,384.10 万股，以此计算合计拟派发现金红 利人民币 23,442.98 万元（含税），占 2025 年半年度合并报表中归属于上 市公司股东净利润的比例为 27.37%。本次利润分配不进行资本公积转增股 本，不派送红股。 如在本公告披露之日起至实施权益分派股权登记日期间公司总股本发 生变动的，公司拟维持每股分配金额不变，相应调整分配总额。如后续总 股本发生变化， ...

宁波远洋运输股份有限公司 第二届董事会第十四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 宁波远洋运输股份有限公司（以下简称"公司"）第二届董事会第十四次会 议于 2025 年 8 月 26 日在宁波市鄞州区宁东路 269 号环球航运广场 39 楼会议室 以现场结合通讯方式召开，会议通知于 2025 年 8 月 15 日以书面、电子邮件等方 式向全体董事会成员发出。 本次会议由公司董事长陈晓峰先生主持，应出席董事 9 名，实际出席董事 9 名，其中 7 名董事现场参会，2 名董事采用通讯方式参会。本次会议的召开符合 《公司法》等有关法律法规及《公司章程》《公司董事会议事规则》的规定。 二、董事会会议审议情况 经审议，会议最终以记名表决方式一致通过了全部议案并形成如下决议： 证券代码：601022 证券简称：宁波远洋 公告编号：2025-030 （一）审议通过了《关于公司 2025 年半年度报告（全文及摘要）的议案》 表决结果：同意 9 票，反对 0 票，弃权 0 票，同意人数占出席会议 ...

Core Viewpoint - The company has implemented a "Quality Improvement and Efficiency Enhancement" action plan for 2024, aimed at improving operational quality and profitability, thereby enhancing investment value and protecting investors' rights [1][2]. Group 1: Company Development and Operational Quality - The company focuses on structural optimization and production-sales coordination, targeting growth markets and customers, with an increased proportion of high-end products [2]. - The company has launched a zero-carbon intelligent manufacturing base in Huai'an, which includes a 233MW wind power project, reinforcing its position in the electronic-grade glass fiber market [3]. - The company has achieved significant milestones in innovation, including 125 patent authorizations in a year, with a focus on automation and production efficiency [4]. Group 2: Governance and Investor Relations - The company is committed to enhancing its governance structure, ensuring compliance with laws and regulations, and protecting the rights of investors, particularly minority shareholders [6][7]. - The company has organized multiple shareholder meetings and board meetings, ensuring compliance with relevant regulations and enhancing transparency [7]. - The company emphasizes high-quality information disclosure, having published 85 announcements in 2024 to improve clarity and accessibility for investors [8][9]. Group 3: ESG Management and Sustainable Development - The company has made significant strides in ESG management, achieving an MSCI ESG rating of "A" and a Wind ESG rating of "AA" [10]. - The company has published its first "Double Carbon" work outline and received the industry's first carbon management system certification, demonstrating its commitment to sustainability [10][11]. Group 4: Investor Returns and Profit Distribution - The company has a robust profit distribution policy, committing to a cash dividend of at least 30% of net profit attributable to shareholders, with a total cash dividend of 10.574 billion yuan since its listing [12]. - In 2025, the company plans to distribute cash dividends amounting to approximately 960.75 million yuan, representing 39.30% of net profit, marking the highest payout ratio in nearly eight years [12].

Core Viewpoint - The company is committed to enhancing operational quality and investor returns through its "Quality Improvement and Efficiency Enhancement Action Plan" for 2025, focusing on core competencies in recombinant protein technology and applications [1][2]. Group 1: Business Performance - The company achieved a revenue of 72.09 million yuan in the first half of 2025, representing a year-on-year increase of 20.85%, driven by improved management, product quality, and expansion into overseas markets [2]. - The recombinant protein business saw a significant growth of 43.66% year-on-year, while the overall customer base increased by 4.2% [2][6]. - The net profit attributable to shareholders was -24.22 million yuan, primarily due to high R&D and marketing investments aimed at high-quality development and reduced government subsidies [2][6]. Group 2: R&D and Innovation - The company emphasizes self-innovation, with 23 core technologies forming 7 comprehensive technology platforms, enhancing its capabilities in product development, production, and quality control [6][7]. - The company is actively developing solutions for various drug types, including RNA vaccines and antibody drugs, and is focusing on areas like organoids and three-dimensional genomics in life sciences [7][8]. Group 3: Investor Relations and Governance - The company has repurchased 404,337 shares for a total of approximately 11.96 million yuan to enhance investor confidence and maintain long-term investment value [8][9]. - The company adheres to strict information disclosure practices, ensuring transparency and communication with investors through multiple channels [9][10]. - The governance structure is continuously optimized to ensure compliance with legal regulations and to protect shareholder rights [10][11]. Group 4: Market Expansion - The company is expanding its overseas market presence by building localized teams and participating in international exhibitions related to antibody drugs and gene therapies [4][5]. - The number of overseas customers increased significantly, reflecting the company's successful market penetration strategies [5]. Group 5: Operational Efficiency - The company is implementing cost-reduction measures and enhancing production efficiency through supply chain integration and local sourcing of raw materials [3][6]. - Quality management systems such as GMP and ISO standards are strictly followed to ensure product safety and effectiveness [3][6]. Group 6: Future Outlook - The company plans to continue evaluating the execution of its action plan while focusing on core business areas and exploring new profit growth points [11]. - The commitment to sustainable long-term returns for investors remains a priority, alongside maintaining operational excellence [11].

Core Viewpoint - Shanghai Shentong Metro Co., Ltd. reported a decrease in revenue and net profit for the first half of 2025, while maintaining a strong operational performance in its public transport management and renewable energy sectors [2][3][4]. Financial Performance - The company achieved operating revenue of approximately 272.28 million yuan, a decrease of 2.79% compared to the same period last year [2]. - The total profit was 42.06 million yuan, down 6.64% year-on-year [2]. - The net profit attributable to shareholders was 27.38 million yuan, reflecting a decline of 6.38% [2]. - The net cash flow from operating activities increased significantly by 180.66%, reaching 345.56 million yuan [2]. Business Segments Public Transport Operations - The company provides operation and maintenance management services for various modes of rail transport, including driverless subways and airport transit systems [3][4]. - The Shanghai Metro Pujiang Line maintained a punctuality rate of 99.91% and a total passenger flow of 5.55 million in the first half of 2025 [4]. - The Pudong Airport Transit Line transported 19.79 million passengers with a punctuality rate of 99.60% [4]. Renewable Energy - The renewable energy segment generated approximately 23.42 million yuan in revenue, a year-on-year increase of 25.79% [4][5]. - The company operates a total installed capacity of 62.4 MWp in photovoltaic projects, ranking first in the national rail transit sector [5][7]. - The total power generation reached approximately 36.08 million kWh, contributing to significant reductions in coal consumption and CO2 emissions [5][7]. Property Management - The property management segment achieved revenue of approximately 101 million yuan, focusing on cleaning and maintenance services [8]. - The company is transitioning from a single business model to a diversified approach, with a focus on facility management as a growing segment [8]. Financing Leasing and Commercial Factoring - The financing leasing company reported revenue of approximately 1.3 million yuan, while the commercial factoring company focused on providing financial support to the rail transit industry [4][8]. Investment Activities - The company invested in various subsidiaries and funds, generating investment income of approximately 7.90 million yuan during the reporting period [4][8].

Core Viewpoint - The company is committed to enhancing its operational quality and performance through strategic initiatives aimed at improving investor returns and maintaining compliance with regulatory standards [1][5]. Group 1: Business Development - The company has achieved breakthroughs in domestic and international markets by leveraging advanced technologies and platform innovations, resulting in a robust order backlog [2][3]. - The company has successfully launched benchmark models tailored for various scenarios, focusing on cost reduction and efficiency across the entire industry chain [2]. - The international business has seen an optimized order structure, particularly in offshore wind power, showcasing the company's global competitiveness [2]. Group 2: Innovation and Technology - The company has integrated AI and distributed architecture in its smart wind farm management, significantly improving operational efficiency and reducing failure rates [2][3]. - Continuous technological advancements are being pursued to enhance the competitiveness of floating wind turbines, ensuring the company remains a leader in clean energy innovation [3]. Group 3: Governance and Compliance - The company is actively revising its internal governance framework to align with the latest corporate laws, ensuring compliance and protecting shareholder rights [3][4]. - A robust profit distribution policy has been implemented, with a cash dividend of 0.3041 yuan per share distributed to shareholders, totaling approximately 653.93 million yuan [4]. Group 4: Investor Relations - The company has enhanced its communication channels with investors, including hosting performance briefings and utilizing various platforms for investor engagement [4][5]. - Efforts are being made to ensure that small and medium investors are informed and can participate in corporate governance effectively [4]. Group 5: Training and Support - The company emphasizes the importance of training for independent directors, facilitating their participation in relevant training programs to support their responsibilities [5].

证券代码：605298 证券简称：必得科技 公告编号：2025-033 二、董事会会议审议情况 本次会议由董事长王坚群先生主持，参加会议的董事审议并以记名方式投票 表决通过了以下议案： 江苏必得科技股份有限公司 第四届董事会第八次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 江苏必得科技股份有限公司（简称"公司"、"必得科技"）于 2025 年 8 月 议通知于 2025 年 8 月 17 日通过书面及电子邮件等方式送达至本公司所有董事、 监事以及高级管理人员。会议应参会董事 8 名，实际参会董事 8 名。监事会成员、 高级管理人员列席了会议。会议的召开符合《中华人民共和国公司法》等有关法 律、行政法规、部门规章、规范性文件和《公司章程》的规定。 （一）审议通过《关于公司 2025 年半年度报告及其摘要的议案》； 表决结果：同意票 8 票、反对票 0 票、弃权票 0 票； 本议案已经公司董事会审计委员会全体成员审议通过，并同意将本议案提交 公司董事会审议。 根据《公开发行证券的公司信息披 ...

证券代码：603296 证券简称：华勤技术 公告编号：2025-081 华勤技术股份有限公司 第二届董事会第十九次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 一、董事会会议召开情况 华勤技术股份有限公司（以下简称"华勤技术"或"公司"）于2025年8月 的通知于2025年8月15日以电子邮件方式发出。会议应出席董事9人，实际出席会 议董事9人，本次会议由董事长邱文生先生主持。本次会议的召集、召开及表决 程序符合有关法律、行政法规、部门规章、规范性文件及《华勤技术股份有限公 司章程》的规定，表决形成的决议合法、有效。 二、董事会会议审议情况 （一）审议通过《关于公司2025年半年度报告及其摘要的议案》 本议案已经公司董事会审计与风险管理委员会审议通过，同意提交董事会审 议。 表决结果：同意9票，反对0票，弃权0票。 表决结果：同意 9 票，反对 0 票，弃权 0 票。 详见公司于同日在上海证券交易所网站（http://www.sse.com.cn）披露的《华 勤技术关于使用自有资金方式支 ...

北京商报讯（记者 胡永新）8月27日晚间，中国人寿保险股份有限公司（以下简称"中国人寿"）发布 2025年半年度报告。报告显示，中国人寿中期现金分红达67.27亿元。这是该公司连续第2年保持中期、 年度两次分红频次。在稳健发展的同时，该公司积极响应"提质增效重回报"专项行动，与投资者共享高 质量发展成果，自上市以来，已累计分红约2277亿元。 ...

北京商报讯（记者 胡永新）8月27日晚间，中国人寿保险股份有限公司（以下简称"中国人寿"）发布 2025年半年度报告。2025年上半年，该公司总保费达5250.88亿元，创历史同期最好水平，同比增长 7.3%，市场份额稳步提升。 此外，中国人寿持续深化资产负债联动，2025年上半年，该公司实现归属于母公司股东的净利润为 409.31亿元，同比增长6.9%。注重增强投资者回报水平和获得感，该公司积极响应"提质增效重回报"专 项行动，与投资者共享高质量发展成果，董事会建议派发2025年中期现金股息每10股2.38元（含税）， 中期现金分红达67.27亿元。 ...